Interpharm Holdings, Inc.
IPAH · OTC
6/30/2007 | 6/30/2006 | 6/30/2005 | 6/30/2004 | |
|---|---|---|---|---|
| Revenue | $76 | $63 | $40 | $41 |
| % Growth | 19.3% | 58.7% | -2.9% | – |
| Cost of Goods Sold | $54 | $46 | $31 | $31 |
| Gross Profit | $22 | $17 | $9 | $10 |
| % Margin | 28.7% | 27.5% | 22.7% | 23.8% |
| R&D Expenses | $19 | $11 | $4 | $1 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $13 | $12 | $5 | $4 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$0 | $0 | $0 | $0 |
| Operating Expenses | $32 | $22 | $9 | $5 |
| Operating Income | -$11 | -$5 | -$0 | $5 |
| % Margin | -14.2% | -7.5% | -0.2% | 12.3% |
| Other Income/Exp. Net | -$3 | -$1 | -$0 | $0 |
| Pre-Tax Income | -$14 | -$5 | -$0 | $5 |
| Tax Expense | $0 | -$2 | -$0 | $2 |
| Net Income | -$14 | -$4 | -$0 | $3 |
| % Margin | -18.6% | -6% | -0.4% | 7.6% |
| EPS | -0.26 | -0.15 | -0.01 | 0.16 |
| % Growth | -73.3% | -1,400% | -106.3% | – |
| EPS Diluted | -0.26 | -0.15 | -0.01 | 0.04 |
| Weighted Avg Shares Out | 65 | 37 | 26 | 18 |
| Weighted Avg Shares Out Dil | 65 | 37 | 26 | 16 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $3 | $2 | $1 | $1 |
| EBITDA | -$8 | -$3 | $1 | $6 |
| % Margin | -10.8% | -5.1% | 2.9% | 14.5% |